The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Apr. 01, 2025
Filed:
May. 16, 2024
Applicant:
Urogen Pharma Ltd., Ra'anana, IL;
Inventor:
Caretha L. Creasy, Philadelphia, PA (US);
Assignee:
UROGEN PHARMA LTD., Ra'anana, IL;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 9/06 (2006.01); A61K 31/403 (2006.01); A61K 31/4738 (2006.01); A61K 31/7072 (2006.01); A61K 47/10 (2017.01); A61P 35/00 (2006.01); C07K 16/28 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
A61K 9/06 (2013.01); A61K 31/403 (2013.01); A61K 31/4738 (2013.01); A61K 31/7072 (2013.01); A61K 47/10 (2013.01); A61P 35/00 (2018.01); C07K 16/2818 (2013.01); A61K 2039/505 (2013.01); A61K 2039/545 (2013.01);
Abstract
Provided herein are compositions and methods for treating cancer of a body cavity, including urinary tract cancer, by way of a combination of at least one immunomodulatory agent, such as a CTLA-4 antibody or TLR agonist, and optionally one chemotherapeutic agent, wherein one or more of the therapeutic agents are embedded in, and slowly released from, a biocompatible hydrogel composition.